(Q24309476)

Vasohibin 1

1 reference

positive regulation of angiogenesis

1 reference

Vasohibin 2

1 reference

Vasohibin 1

1 reference

1 reference

10

Yasufumi Sato

0 references

author name string

Hiroshi Kimura

1

0 references

Hiroki Miyashita

2

0 references

Yasuhiro Suzuki

3

0 references

Miho Kobayashi

4

0 references

Kazuhide Watanabe

5

0 references

Hikaru Sonoda

6

0 references

Hideki Ohta

7

0 references

Takashi Fujiwara

8

0 references

Tooru Shimosegawa

Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells

9

0 references

language of work or name

English

0 references

publication date

7 May 2009

0 references

published in

Blood

0 references

volume

113

0 references

issue

19

0 references

page(s)

4810-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Vasohibin prevents arterial neointimal formation through angiogenesis inhibition

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Maspin is an angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

WAVE2 is required for directed cell migration and cardiovascular development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Basement membranes: structure, assembly and role in tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Molecular regulation of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Update on endogenous inhibitors of angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Dosage-sensitive requirement for mouse Dll4 in artery development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Angiogenic role of LYVE-1-positive macrophages in adipose tissue.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

Expression and regulation of tumor suppressor gene maspin in breast cancer

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2008-07-170316

7 January 2021

10.1182/BLOOD-2008-07-170316

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4596946

4596946

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference